Assessment of salivary immunoglobulin A, interleu-kin-6 and C-reactive protein in chronic kidney dis-ease patients on hemodialysis and on conservative treatment
Main Article Content
Background: Chronic kidney disease is a gradual loss of kidney function with diabetes and hypertension as the leading cause. Chronic kidney disease is one of these systemic diseases that can affect salivary contents. Aims: This study aimed to assess salivary immunoglobulin A, interleukin-6 and C- reactive protein in chronic kidney disease patients on hemodialysis and those on conservative treatment in comparison with control subjects. Materials and methods: Ninety subjects were included in this study divided into three groups: 30 patients with chronic kidney disease on hemodialysis for at least 6 months ago; 30 patients with chronic kidney disease on conservative treatment and 30 healthy control subjects. Secretory immunoglobulin A, interleukin-6 and C- reactive protein in saliva samples were measured by enzyme-linked immunosorbent assay ELISA. Results: No significant difference in salivary immunoglobulin A level among study groups was seen. A significant increase in salivary interleukin-6 and C- reactive protein in both chronic kidney disease patients on hemodialysis and those on conservative treatment compared to the control group. While, no significant salivary IL-6 and CRP differences were seen between both patient groups, on hemodialysis and conservative treatment. Conclusions: There was no significant difference among chronic kidney disease patients on hemodialysis, on conservative treatment and control healthy subjects regarding to salivary IgA while Salivary interleukin -6 and C- reactive protein was significantly higher in chronic kidney disease patients on hemodialysis and those on conservative treatment compared to healthy subjects.
Received date: 15-1-2022
Accepted date: 1-3-2022
This work is licensed under a Creative Commons Attribution 4.0 International License.
Licenses and Copyright
The following policy applies in The Journal of Baghdad College of Dentistry (JBCD):
# JBCD applies the Creative Commons Attribution (CC BY) license to articles and other works we publish. If you submit your paper for publication by JBCD, you agree to have the CC BY license applied to your work. Under this Open Access license, you as the author agree that anyone can reuse your article in whole or part for any purpose, for free, even for commercial purposes. Anyone may copy, distribute, or reuse the content as long as the author and original source are properly cited. This facilitates freedom in re-use and also ensures that JBCD content can be mined without barriers for the needs of research.
# If your manuscript contains content such as photos, images, figures, tables, audio files, videos, etc., that you or your co-authors do not own, we will require you to provide us with proof that the owner of that content (a) has given you written permission to use it, and (b) has approved of the CC BY license being applied to their content. We provide a form you can use to ask for and obtain permission from the owner. If you do not have owner permission, we will ask you to remove that content and/or replace it with other content that you own or have such permission to use.Don't assume that you can use any content you find on the Internet, or that the content is fair game just because it isn't clear who the owner is or what license applies.
# Many authors assume that if they previously published a paper through another publisher, they own the rights to that content and they can freely use that content in their paper, but thatâ€™s not necessarily the case, it depends on the license that covers the other paper. Some publishers allow free and unrestricted re-use of article content they own, such as under the CC BY license. Other publishers use licenses that allow re-use only if the same license is applied by the person or publisher re-using the content. If the paper was published under a CC BY license or another license that allows free and unrestricted use, you may use the content in your JBCD paper provided that you give proper attribution, as explained above.If the content was published under a more restrictive license, you must ascertain what rights you have under that license. At a minimum, review the license to make sure you can use the content. Contact that JBCD if you have any questions about the license. If the license does not permit you to use the content in a paper that will be covered by an unrestricted license, you must obtain written permission from the publisher to use the content in your JBCD paper. Please do not include any content in your JBCD paper which you do not have rights to use, and always give proper attribution.
# If any relevant accompanying data is submitted to repositories with stated licensing policies, the policies should not be more restrictive than CC BY.
# JBCD reserves the right to remove any photos, captures, images, figures, tables, illustrations, audio and video files, and the like, from any paper, whether before or after publication, if we have reason to believe that the content was included in your paper without permission from the owner of the content.
Venkatapathy, R., Govindarajan, V., Oza, N., Parameswaran, S., Pennagaram Dhanasekaran, B., & Prashad, K. V. Salivary creatinine estimation as an alternative to serum creatinine in chronic kidney disease patients. Int. J.nephrol.2014.
Levey, A.S., Eckardt, K.U., Tsukamoto, Y., Levin, A., Coresh, J., Rossert, J., Zeeuw, D.D., Hostetter, T.H., Lameire, N. and Eknoyan, G. Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). KI. 2005; 67(6): .2089-2100.
Levin, A., Stevens, P.E., Bilous, R.W., Coresh, J., De Francisco, A.L., De Jong, P.E., Griffith, K.E., Hemmelgarn, B.R., Iseki, K., Lamb, E.J. and Levey, A.S. Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. KI Supplements. 2013; 3(1): 1-150.
Dağ, A., Fırat, E.T., Kadiroğlu, A.K., Kale, E. and Yılmaz, M.E. Significance of elevated gingival crevicular fluid tumor necrosis factor‐α and interleukin‐8 levels in chronic hemodialysis patients with periodontal disease. J. periodontal res. 2010; 45(4): 445-450.
Fenton, S.S., Schaubel, D.E., Desmeules, M., Morrison, H.I., Mao, Y., Copleston, P., Jeffery, J.R. and Kjellstrand, C.M. Hemodialysis versus peritoneal dialysis: a comparison of adjusted mortality rates. Am, J. Kidney Dis. 1997; 30(3): 334-342.
Craig, R.G. Interactions between chronic renal disease and periodontal disease. Oral Dis. 2008; 14(1): 1-7.
Glick M. and Feagans WM. Burket's Oral Medicine, ed 12. Shelton, People's Medical publishing house-USA, 2015.
McMillan, R., Skiadopoulos, L., Hoppensteadt, D., Guler, N., Bansal, V., Parasuraman, R. and Fareed, J. Bi-omarkers of endothelial, renal, and platelet dysfunction in stage 5 chronic kidney disease hemodialysis patients with heart failure. CATH. 2018; 24(2): 235-240.
Seraj, B., Ahmadi, R., Ramezani, N., Mashayekhi, A. and Ahmadi, M. Oro-dental health status and salivary characteristics in children with chronic renal failure. J. Dent. 2011; (Tehran, Iran), 8(3): 146.
Bagalad, B.S., Mohankumar, K.P., Madhushankari, G.S., Donoghue, M. and Kuberappa, P.H. Diagnostic accuracy of salivary creatinine, urea, and potassium levels to assess dialysis need in renal failure patients. DRJ. 2017; 14(1): 13.
Lasisi, T.J., Raji, Y.R. and Salako, B.L. Salivary creatinine and urea analysis in patients with chronic kidney dis-ease: a case control study. BMC nephrol. 2016; 17(1): 10.
Hand, T.W. and Reboldi, A. Production and function of Immunoglobulin A. Annual review of immunology. 2021; 39: 695-718.
Eleftheriadis, T., Antoniadi, G., Liakopoulos, V., Kartsios, C. and Stefanidis, I. Basic science and dialysis: dis-turbances of acquired immunity in hemodialysis patients. In Semin. Dial. (Vol. 20, No. 5: 440-451). Oxford, UK: Blackwell Publishing Ltd. september 2007.
Toshio Hirano. IL-6 in inflammation, autoimmunity and cancer. Int. Immunol., Volume 33, Issue 3, March 2021; Pages 127–148.
Schmit, X. and Vincent, J.L. The time course of blood C-reactive protein concentrations in relation to the response to initial antimicrobial therapy in patients with sepsis. Infect. 2008; 36(3): 213-219.
Khozeymeh, F., Mortazavi, M., Khalighinejad, N., Akhavankhaleghi, M., Alikhani, M. Salivary levels of inter-leukin-6 and tumor necrosis factor-alpha in patients undergoing hemodialysis. Dent. Res. J. 2016; 13, 69–73.
Nibali, L., Fedele, S., D’aiuto, F. and Donos, N. Interleukin‐6 in oral diseases: a review. Oral dis. 2012; 18(3), pp.236-243.
Denic, A., Glassock, R.J. and Rule, A.D. Structural and functional changes with the aging kidney. Adv. chronic kidney Dis. 2016; 23(1): 19-28.
Goldberg, I. and Krause, I. The role of gender in chronic kidney disease. EMJ. 2016; 1(2), pp.58-64.
Ahmed, K.M., Mahmood, M.A., Abdulraheam, R.H. and Ahmed, S.M. Oral and Dental Findings in Patients with End Stage Renal Disease Undergoing Maintenance Hemodialysis in Sulaimani City. J Interdiscipl Med Dent Sci. 2015; 3(182): 2.
Huda MN, Alam KS, Harun Ur R. Prevalence of chronic kidney disease and its association with risk factors in disadvantageous population. Int. J. Nephrol. 2012; 2012:267329.
Pinho, N.A.D., Oliveira, R.D.C.B.D. and Pierin, A.M.G. Hypertensive patients with and without kidney disease: assessment of risk factors. Rev. Esc. Enferm. USP. 2015; 49(SPE): 101-108.
Pierin, A.M.G., Jesus, E.D.S., Augusto, M.A.D.O., Gusmão, J., Ortega, K. and Mion Jr, D. Biopsychosocial varia-bles and attitudes towards treatment influence complicated hypertension. Arq. Bras. Cardio. 2010; 95(5): 648-654.
Yacoub, R., Habib, H., Lahdo, A., Al Ali, R., Varjabedian, L., Atalla, G., Akl, N.K., Aldakheel, S., Alahdab, S. and Albitar, S. Association between smoking and chronic kidney disease: a case control study. BMC public health. 2010; 10(1): 731.
Nagasawa, Y., Yamamoto, R., Rakugi, H. and Isaka, Y. Cigarette smoking and chronic kidney diseases. Hyper… Res. 2012; 35(3): 261.
Júnior, E., Fernando, U., Elihimas, H.C.D.S., Lemos, V.M., Leão, M.D.A., Sá, M.P.B.D.O., França, E.E.T.D., Lemos, A., Valente, L.M. and Markman Filho, B. Smoking as risk factor for chronic kidney disease: systematic review. Jornal Brasileiro de Nefrologia. 2014; 36(4): 519-528.
Lea, J.P. and Nicholas, S.B. Diabetes mellitus and hypertension: key risk factors for kidney disease. J. Natl. Med. Assoc. 2002; 94(8 Suppl), p.7S.
Kabir, M.S., Dutta, P.K., Islam, M.N., Hasan, M.J. and Mondol, G. Prevalence of risk factors of chronic kidney disease in adults. MMJ. : MMJ. 2012; 21(4): 605-610.
Bramlage, P., Lanzinger, S., van Mark, G., Hess, E., Fahrner, S., Heyer, C.H., Friebe, M., Seufert, J., Danne, T. and Holl, R.W. Patient and disease characteristics of type-2 diabetes patients with or without chronic kidney disease: an analysis of the German DPV and DIVE databases. Cardiovas. diabetol. 2019; 18(1): 1-12.
Kazancioğlu, R., 2013. Risk factors for chronic kidney disease: an update. Kidney international supplements, 3(4): 368-371.
Orantes, C.M., Herrera, R., Almaguer, M., Brizuela, E.G., Hernández, C.E., Bayarre, H., Amaya, J.C., Calero, D.J., Orellana, P., Colindres, R.M. and Velázquez, M.E. Chronic kidney disease and associated risk factors in the Bajo Lempa region of El Salvador: Nefrolempa study, 2009. MEDICC review. 2011; 13: 14-22.
Konstantinova, D., Nenova-Nogalcheva, А. and Tancheva, S. December. Saliva as an alternative medium for testing secretory immunoglobulin (SIGA) in patients with end-stage chronic kidney disease on renal replacement therapy. In Варненски медицински форум (Varna Medical Forum). 2017; Vol. 6, No. 2: 42-46.
Staykova, S.V., Atanasova, S. and Koycheva, R. Bone-Dental Changes – Siga and Halitosis in Bulgarian Patients with Chronic Kidney Disease and Secondary Hyperparathyroidism. IOSR J. Dent. Sci. (IOSR-JDMS). 2018; 17(3): 70-73.
Ersson, C., Thorman, R., Rodhe, Y., Möller, L., and Hylander, B. DNA damage in salivary gland tissue in patients with chronic kidney disease, measured by the comet assay. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2011; 112(2): 209-215.
Shlipak, M.G., Fried, L.F., Crump, C., Bleyer, A.J., Manolio, T.A., Tracy, R.P., Furberg, C.D. and Psaty, B.M. El-evations of inflammatory and procoagulant biomarkers in elderly persons with renal insufficiency. Circulation. 2003; 107(1): 87-92.
Pallos, D., Leão, M.V., Togeiro, F.C., Alegre, L., Ricardo, L.H., Perozini, C. and Ruivo, G.F. Salivary markers in patients with chronic renal failure. Arch. oral biol. 2015; 60(12): 1784-1788.
Adejumo, O. A., Okaka, E. I., Okwuonu, C. G., Iyawe, I. O., and Odujoko, O. O. Serum C-reactive protein levels in pre-dialysis chronic kidney disease patients in southern Nigeria. Ghana. M. J. 2016; 50(1): 31-38.
Chambrone, L., Foz, A. M., Guglielmetti, M. R., Pannuti, C. M., Artese, H. P., Feres, M. and Romito, G. A. Per-iodontitis and chronic kidney disease: a systematic review of the association of diseases and the effect of perio-dontal treatment on estimated glomerular filtration rate. J. Clin. Periodontol. 2013; 40(5): 443–456.
Gomes‐Filho, I.S., Freitas Coelho, J.M., da Cruz, S.S., Passos, J.S., Teixeira de Freitas, C.O., Aragão Farias, N.S., Amorim da Silva, R., Silva Pereira, M.N., Lima, T.L. and Barreto, M.L. Chronic periodontitis and C‐reactive protein levels. J. of periodontal. 2011; 82(7): 969-978.
Goyal, L., Bey, A., Gupta, N.D. and Sharma, V.K. Comparative evaluation of serum C-reactive protein levels in chronic and aggressive periodontitis patients and association with periodontal disease severity. Contemp. Clin. Dent. 2014; 5(4): 484.
Bansal, T., Pandey, A., Deepa, D. and Asthana, A.K. C-reactive protein (CRP) and its association with periodontal disease: a brief review. JCDR. 2014; 8(7), p.ZE21.
Eklund, C.M., 2009. Proinflammatory cytokines in CRP baseline regulation. Adv. Clin. chem. 48: 111-136.
Hamissi, J., Porsamimi, J., Naseh, M.R. and Mosalaei, S. Oral hygiene and periodontal status of hemodialyzed patients with chronic renal failure in Qazvin, Iran. East Afr. J. Puplic Health. 2009; 6(1).
Lasisi, T.J., Duru, M.E. and Lawal, B.B. Salivary Secretion and Composition in Malaria: A Case-control Study. Niger. J. Physiol. Sci.. 2015; 30(1-2): 119-123.
Süleymanlar, G., Altıparmak, M.R. and Seyahi, N. Turkish Society of Nephrology, Registry of the Nephrology. Dialysis and Transplantation in Turkey. 2011.
Venkatapathy, R., Govindarajan, V., Oza, N., Parameswaran, S., Pennagaram Dhanasekaran, B. and Prashad, K.V. Salivary creatinine estimation as an alternative to serum creatinine in chronic kidney disease patients. Int. J. nephrol. 2014.